10/30/2024
5:15 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
5:17 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
10/15/2024
12:45 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:30 PM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:32 PM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
09/11/2024
4:17 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:39 PM | Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/13/2024
5:34 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:02 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:11 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
08/09/2024
8:43 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
08/05/2024
11:54 AM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
07/15/2024
6:55 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
6:59 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
07/12/2024
3:55 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
5:20 PM | Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
5:26 PM | Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
6:04 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
06/28/2024
6:33 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
6:36 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
06/27/2024
4:01 PM | Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:01 PM | CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:02 PM | DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:04 PM | Altschuler Steven (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:05 PM | COOPERSTONE BRENDA (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
8:04 AM | Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:04 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
4:14 PM | Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
6:02 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:07 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:09 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/26/2024
6:55 AM | Lexeo Therapeutics (Filer)
Lexeo Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
6:56 AM | Lexeo Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:57 AM | Lexeo Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:57 AM | Lexeo Therapeutics (Filer)
| Form ARS | |
04/22/2024
7:22 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
7:23 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
7:24 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
7:11 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Why Buffett, Bezos, & Congress Are Piling Into This One Sector (Ad) Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy?
And why are they all piling into ONE unique corner of the market… Click here for the details |
04/16/2024
6:35 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/16/2024
6:32 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2024
11:15 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
04/12/2024
4:04 PM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/09/2024
7:01 AM | Lexeo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/11/2024
8:29 AM | Lexeo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
3:43 PM | Lexeo Therapeutics (Subject)
Omega Fund VI, L.P. (Filed by)
| Form SC 13G | |
02/14/2024
3:34 PM | Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G | |
02/14/2024
12:43 PM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
5:04 AM | D1 Capital Partners L.P. (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G | |
02/06/2024
4:56 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:57 PM | Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:58 PM | DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:58 PM | Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2024
6:03 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
5:50 PM | Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:52 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
6:00 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
3:51 PM | Lexeo Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G/A | |
12/11/2023
6:02 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/11/2023
6:03 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
3:33 PM | Lexeo Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G | |
11/09/2023
7:35 PM | Lexeo Therapeutics (Issuer)
McCormac Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:36 PM | Lexeo Therapeutics (Issuer)
Nessi Claudio (Reporting)
Omega Fund VI GP Manager, Ltd. (Reporting)
Omega Fund VI GP, L.P. (Reporting)
Omega Fund VI, L.P. (Reporting)
Paster Anne-Mari (Reporting)
Stampacchia Otello (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:32 PM | ENRIGHT PATRICK G (Reporting)
Lexeo Therapeutics (Issuer)
Longitude Capital Partners IV, LLC (Reporting)
Longitude Venture Partners IV, L.P. (Reporting)
Tammenoms Bakker Juliet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:33 PM | Lexeo Therapeutics (Issuer)
Lundbeckfond Invest A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:13 PM | Lexeo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/02/2023
8:01 PM | Lexeo Therapeutics (Subject)
| Form FWP | |
11/02/2023
11:16 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
11/02/2023
8:37 PM | Lexeo Therapeutics (Issuer)
Lundbeckfond Invest A/S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:38 PM | Lexeo Therapeutics (Issuer)
McCormac Paul (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:40 PM | Lexeo Therapeutics (Issuer)
Nessi Claudio (Reporting)
Omega Fund VI GP Manager, Ltd. (Reporting)
Omega Fund VI GP, L.P. (Reporting)
Omega Fund VI, L.P. (Reporting)
Paster Anne-Mari (Reporting)
Stampacchia Otello (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:41 PM | Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:42 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:36 PM | ENRIGHT PATRICK G (Reporting)
Lexeo Therapeutics (Issuer)
Longitude Capital Partners IV, LLC (Reporting)
Longitude Venture Partners IV, L.P. (Reporting)
Tammenoms Bakker Juliet (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:16 PM | Altschuler Steven (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:17 PM | CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:19 PM | COOPERSTONE BRENDA (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:24 PM | Davitian Bernard (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:26 PM | DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:14 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:15 PM | Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
